155 related articles for article (PubMed ID: 35094817)
21. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
Flood TF; Stence NV; Maloney JA; Mirsky DM
Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
[TBL] [Abstract][Full Text] [Related]
22. Diffusion-weighted imaging of the dentate nucleus after repeated application of gadolinium-based contrast agents in multiple sclerosis.
Eisele P; Szabo K; Ebert A; Radbruch A; Platten M; Schoenberg SO; Gass A
Magn Reson Imaging; 2019 May; 58():1-5. PubMed ID: 30630068
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
[TBL] [Abstract][Full Text] [Related]
24. Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.
Conte G; Preda L; Cocorocchio E; Raimondi S; Giannitto C; Minotti M; De Piano F; Petralia G; Ferrucci PF; Bellomi M
Eur Radiol; 2017 Oct; 27(10):4372-4378. PubMed ID: 28357495
[TBL] [Abstract][Full Text] [Related]
25. The switch from Gd-DTPA to Gd-DOTA is not associated with decrease of the T1 signal intensity of the pallidus and dentate in a pediatric population.
Gulino P; Bianchi A; Diciotti S; Scionti A; Sali L; Papadopulos P; Mascalchi M
Acta Radiol; 2021 Mar; 62(3):368-376. PubMed ID: 32529894
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of 3.0-T MRI Brain Signal after Exposure to Gadoterate Meglumine in Women with High Breast Cancer Risk and Screening Breast MRI.
Bennani-Baiti B; Krug B; Giese D; Hellmich M; Bartsch S; Helbich TH; Baltzer PAT
Radiology; 2019 Dec; 293(3):523-530. PubMed ID: 31638488
[TBL] [Abstract][Full Text] [Related]
27. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
28. Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration.
Weberling LD; Kieslich PJ; Kickingereder P; Wick W; Bendszus M; Schlemmer HP; Radbruch A
Invest Radiol; 2015 Nov; 50(11):743-8. PubMed ID: 26352749
[TBL] [Abstract][Full Text] [Related]
29. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
30. Higher magnetic susceptibility of globus pallidus in patients after macrocyclic GBCAs: assessment using quantitative susceptibility mapping.
Zhang J; Xie L; Yang X; Xu L; Chen K; Luo Y; Yu C
Acta Radiol; 2023 Jul; 64(7):2261-2267. PubMed ID: 36567675
[TBL] [Abstract][Full Text] [Related]
31. Gadoxetate disodium, a modern hepatospecific MRI contrast agent: Indirect signs for gadolinium deposition in the brain structures with signal intensity increase after intravenous application.
Holesta M; Weichet J; Wagnerova MG; Lukavsky J; Malikova H
Neurol India; 2018; 66(6):1771-1775. PubMed ID: 30504579
[TBL] [Abstract][Full Text] [Related]
32. Signal changes in enhanced T1-weighted images related to gadolinium retention: A three-time-point imaging study.
Lersy F; Diepenbroek AL; Lamy J; Willaume T; Bierry G; Cotton F; Kremer S
J Neuroradiol; 2021 Mar; 48(2):82-87. PubMed ID: 32615207
[TBL] [Abstract][Full Text] [Related]
33. High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol.
Radbruch A; Weberling LD; Kieslich PJ; Hepp J; Kickingereder P; Wick W; Schlemmer HP; Bendszus M
Invest Radiol; 2015 Dec; 50(12):805-10. PubMed ID: 26523910
[TBL] [Abstract][Full Text] [Related]
34. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
35. Progressive T1 Shortening of the Dentate Nucleus in Patients With Multiple Sclerosis: Result of Multiple Administrations of Linear Gadolinium Contrast Agents Versus Intrinsic Disease.
Malhotra A; LeSar B; Wu X; Durand D; Das N; Anzai Y; Sanelli P
AJR Am J Roentgenol; 2018 Nov; 211(5):1099-1105. PubMed ID: 30160975
[TBL] [Abstract][Full Text] [Related]
36. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted MR Images: Comparison between Gadobutrol and Linear Gadolinium-Based Contrast Agents.
Moser FG; Watterson CT; Weiss S; Austin M; Mirocha J; Prasad R; Wang J
AJNR Am J Neuroradiol; 2018 Mar; 39(3):421-426. PubMed ID: 29419400
[TBL] [Abstract][Full Text] [Related]
37. Age, But Not Repeated Exposure to Gadoterate Meglumine, Is Associated With T1- and T2-Weighted Signal Intensity Changes in the Deep Brain Nuclei of Pediatric Patients.
Pozeg P; Forget J; Meuli RA; Maeder P
Invest Radiol; 2019 Sep; 54(9):537-548. PubMed ID: 30973458
[TBL] [Abstract][Full Text] [Related]
38. Does renal function affect gadolinium deposition in the brain?
Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
[TBL] [Abstract][Full Text] [Related]
39. Quantitative assessment of gadolinium deposition in dentate nucleus using quantitative susceptibility mapping.
Hinoda T; Fushimi Y; Okada T; Arakawa Y; Liu C; Yamamoto A; Okada T; Yoshida K; Miyamoto S; Togashi K
J Magn Reson Imaging; 2017 May; 45(5):1352-1358. PubMed ID: 27664936
[TBL] [Abstract][Full Text] [Related]
40. Impact of nasopharyngeal irradiation and gadolinium administration on changes in T
Tang R; Haacke EM; Zhang Y; Wang Q; He N; Chen KM; Yan F
J Magn Reson Imaging; 2020 Jan; 51(1):250-259. PubMed ID: 31124193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]